FDA inspection
Anicare Pharmaceuticals Pvt Ltd.: FDA inspection ending Aug 3, 2018
FDA inspection 1061011 · Official Action Indicated (OAI) · Navi Mumbai
Key facts
| Inspection ID | 1061011 |
|---|---|
| Firm | Anicare Pharmaceuticals Pvt Ltd. |
| FEI number | 3007450508 |
| Address | Plot No. A-143 / 5 & 6, Ttc Ind. Area, Khairne M.I.D.C, Thane-Belapur Rd, Behind Midc Fire Station |
| City | Navi Mumbai |
| Country | India |
| Fiscal year | 2018 |
| Inspection end date | Aug 3, 2018 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 569251 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data